• Mon, January 11, 2021
Thomas Shrader Initiated (BCAB) at Strong Buy and Held Target at $47 on, Jan 11th, 2021
Thomas Shrader of BTIG, Initiated "BioAtla, Inc." (BCAB) at Strong Buy and Held Target at $47 on, Jan 11th, 2021.
Thomas, nor any peers, have made any analyst calls on BCAB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30